Nasdaq

First ReWalk Personal Exoskeleton Claim Paid by Medicare

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable ...
Seeking Alpha

Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to ...

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskel…

Global data since 2013 show just 3% lifetime fracture prevalence, declining to 0.3% over the past six years Zero fractures ...
Business Insider

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...
Nasdaq

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal ...
WDTN

ReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum Basis

Proposed benefit category assignment represents a positive step in facilitating Medicare coverage of personal exoskeletons for qualified individuals with spinal cord injury (SCI). ReWalk Robotics is ...